The effectiveness of therapy was evaluated individually using the Crohn’s Disease Activity Index (CDAI) in patients with CD or the Mayo Scoring System (MSS) in patients with UC, and also by endoscopy and C-reactive protein (CRP) values, after 14 weeks of therapy. Here, CRP is linked to Crohn disease.